Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-017001
Filing Date
2020-06-18
Accepted
2020-06-18 08:30:45
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4069
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4427
  Complete submission text file 0000899243-20-017001.txt   10117
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BEIER DAVID W (Reporting) CIK: 0001187054 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 20971293